Superannuation funds Hostplus and HESTA, biotech giant CSL and the Queensland Investment Corporation have poured $270 million into a new fund for venture capital firm Brandon Capital, which it plans to keep raising until it hits a $350 million target.
Brandon Capital is Australia’s largest life science investment fund, having started with a $30 million fund in 2007, and since raising more than $1 billion across its funds to invest in healthcare and biotech start-ups. Its latest fund will be known as Brandon Biocatalyst 6.
Loading...
Tess Bennett is a technology reporter with The Australian Financial Review, based in the Brisbane newsroom. She was previously the work & careers reporter. Connect with Tess on Twitter. Email Tess at tess.bennett@afr.com
